Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds.
Cuprina Holdings stock last closed at $4.85, down 2.02% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Cuprina Holdings stock is currently +38.18% from its 52-week low of $3.51, and -16.52% from its 52-week high of $5.81.
How to Buy Cuprina Holdings Stock
Wondering how to invest in Cuprina Holdings stock? Here's how.
Figure out where to buy Cuprina Holdings stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Cuprina Holdings stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Select your payment method and add your details.
Evaluate Cuprina Holdings stock: The Cuprina Holdings ticker symbol is CUPR. Is Cuprina Holdings stock a good investment? Should you buy shares of CUPR? How do CUPR's underlying business fundamentals look? Do top analysts think Cuprina Holdings is a good buy? Why has CUPR's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if CUPR is a good stock to buy).
Execute your CUPR purchase: Decide if you will purchase CUPR shares at the current market price or use a limit order to purchase CUPR shares at a particular price.
Monitor your CUPR position: Create a watchlist to track your position in Cuprina Holdings shares.
Step 1: Figure out where to buy Cuprina Holdings stock
You will need a brokerage account to access the NASDAQ market and buy CUPR stock.
A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world markets: From Technology to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal information so you can buy CUPR today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Cuprina Holdings stock
After you have identified the best place to buy Cuprina Holdings stock, it's crucial to evaluate their stock prior to investing, so you truly comprehend the risk as well as the upside.
Cuprina Holdings shares at a glance
CUPR Price
$4.85
1w %
6.36%
1y %
N/A
5y %
N/A
P/E
-86.61x
P/B
N/A
P/S
1,212.5x
PEG
N/A
Revenue
$71.92k
Earnings
-$1.02M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
N/A
Next Earnings
N/A
Next Dividend
N/A
CUPR Overview
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
There are more short-term assets than long-term liabilities on the CUPR balance sheet.
Negative Financial Indicators:
CUPR profit margin has gone down from -1,367.7% to -1,412.1% in the past year.
CUPR debt to equity ratio of -1.47 is negative.
CUPR has cash burn of 1295574. It does not have enough cash and short-term investments to cover this.
Total CUPR debt is still negative.
CUPR has $55.45k in cash and short term investments. This is not enough to cover its annual cash burn of $1.30M.
There are more short-term liabilities than short-term assets on the CUPR balance sheet.
CUPR Growth Metrics
Last year, CUPR revenue was $71.92k. Over the past 1 years, CUPR's revenue has grown by 32.39% per year. This was slower than the Biotechnology industry average of 44.31%.
No, Cuprina Holdings doesn't provide an income stream by paying out dividends.
CUPR Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your CUPR purchase
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly fine for most investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a given price, place a limit order.
Click the Open button and your broker will place the order.
If you need additional assistance investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Cuprina Holdings share?
As of Apr 21, 2025, it costs $4.85 to buy one share of Cuprina Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.412 shares of CUPR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.